Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geny Piro

Showing results (21-30 of 60) with videos related to

Pageof 6
Sort By:
Critical Reviews in Oncology/Hematology|June 21, 2022
Targeting hypoxia-inducible factor pathways in sporadic and Von Hippel-Lindau syndrome-related kidney cancersRoberto Iacovelli, Daniela Arduini, Chiara Ciccarese, et al.
Molecular Cancer Therapeutics|June 14, 2019
Vorinostat Potentiates 5-Fluorouracil/Cisplatin Combination by Inhibiting Chemotherapy-Induced EGFR Nuclear Translocation and Increasing Cisplatin UptakeGeny Piro, Maria Serena Roca, Francesca Bruzzese, et al.
Frontiers in Medicine|January 10, 2022
Pancreatic Cancer Patient-Derived Organoid Platforms: A Clinical Tool to Study Cell- and Non-Cell-Autonomous Mechanisms of Treatment ResponseGeny Piro, Antonio Agostini, Alberto Larghi, et al.
Molecular Cancer Therapeutics|September 29, 2019
Modulating TAK1 Expression Inhibits YAP and TAZ Oncogenic Functions in Pancreatic CancerRaffaela Santoro, Marco Zanotto, Francesca Simionato, et al.
Molecular Neurobiology|October 10, 2022
CSF CXCL13 and Chitinase 3-like-1 Levels Predict Disease Course in Relapsing Multiple SclerosisMatteo Lucchini, Valeria De Arcangelis, Geny Piro, et al.
Brain Sciences|December 23, 2022
Serum Inflammatory Profile in Hereditary Transthyretin Amyloidosis: Mechanisms and Possible Therapeutic ImplicationsMarco Luigetti, Angela Romano, Valeria Guglielmino, et al.
Oncotarget|November 1, 2014
An angiopoietin-like protein 2 autocrine signaling promotes EMT during pancreatic ductal carcinogenesisCarmine Carbone, Geny Piro, Matteo Fassan, et al.
Anti-Cancer Drugs|October 17, 2015
Combined inhibition of IL1, CXCR1/2, and TGFβ signaling pathways modulates in-vivo resistance to anti-VEGF treatmentCarmine Carbone, Anna Tamburrino, Geny Piro, et al.
Cancers|August 14, 2019
PTEN in Lung Cancer: Dealing with the Problem, Building on New Knowledge and Turning the Game AroundAnastasios Gkountakos, Giulia Sartori, Italia Falcone, et al.
Mediators of Inflammation|December 13, 2019
Lung and Gut Microbiota as Potential Hidden Driver of Immunotherapy Efficacy in Lung CancerCarmine Carbone, Geny Piro, Vincenzo Di Noia, et al.
Pageof 6

Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
Critical Reviews in Oncology/Hematology|June 21, 2022
Targeting hypoxia-inducible factor pathways in sporadic and Von Hippel-Lindau syndrome-related kidney cancersRoberto Iacovelli, Daniela Arduini, Chiara Ciccarese, et al.
Molecular Cancer Therapeutics|June 14, 2019
Vorinostat Potentiates 5-Fluorouracil/Cisplatin Combination by Inhibiting Chemotherapy-Induced EGFR Nuclear Translocation and Increasing Cisplatin UptakeGeny Piro, Maria Serena Roca, Francesca Bruzzese, et al.
Frontiers in Medicine|January 10, 2022
Pancreatic Cancer Patient-Derived Organoid Platforms: A Clinical Tool to Study Cell- and Non-Cell-Autonomous Mechanisms of Treatment ResponseGeny Piro, Antonio Agostini, Alberto Larghi, et al.
Molecular Cancer Therapeutics|September 29, 2019
Modulating TAK1 Expression Inhibits YAP and TAZ Oncogenic Functions in Pancreatic CancerRaffaela Santoro, Marco Zanotto, Francesca Simionato, et al.
Molecular Neurobiology|October 10, 2022
CSF CXCL13 and Chitinase 3-like-1 Levels Predict Disease Course in Relapsing Multiple SclerosisMatteo Lucchini, Valeria De Arcangelis, Geny Piro, et al.
Brain Sciences|December 23, 2022
Serum Inflammatory Profile in Hereditary Transthyretin Amyloidosis: Mechanisms and Possible Therapeutic ImplicationsMarco Luigetti, Angela Romano, Valeria Guglielmino, et al.
Oncotarget|November 1, 2014
An angiopoietin-like protein 2 autocrine signaling promotes EMT during pancreatic ductal carcinogenesisCarmine Carbone, Geny Piro, Matteo Fassan, et al.
Anti-Cancer Drugs|October 17, 2015
Combined inhibition of IL1, CXCR1/2, and TGFβ signaling pathways modulates in-vivo resistance to anti-VEGF treatmentCarmine Carbone, Anna Tamburrino, Geny Piro, et al.
Cancers|August 14, 2019
PTEN in Lung Cancer: Dealing with the Problem, Building on New Knowledge and Turning the Game AroundAnastasios Gkountakos, Giulia Sartori, Italia Falcone, et al.
Mediators of Inflammation|December 13, 2019
Lung and Gut Microbiota as Potential Hidden Driver of Immunotherapy Efficacy in Lung CancerCarmine Carbone, Geny Piro, Vincenzo Di Noia, et al.
Pageof 6